Group 1 - Aja Health and Wellness Inc. announces a broker agreement with Greatway Financial Inc. for marketing its MyCare Ally program across Canada, excluding Quebec, with marketing initiatives set to launch on February 7, 2026 [2] - MyCare Ally is a comprehensive healthcare support service offering personalized assistance, initial diagnosis by healthcare professionals, independent clinical reviews, virtual medical care through GOeVisit, and access to a secure digital health information portal [3] - Aja Health Inc. will transition its GOeVisit platform to a new Electronic Medical Records (EMR) software system on January 28, 2026, enhancing functionality and expanding services, including weight management programs and virtual testing [4]

Core Insights - Omada Health announced preliminary, unaudited revenue for Q4 and fiscal year 2025, indicating strong growth ahead of the J.P. Morgan Healthcare Conference [1][4] Financial Performance - Q4 2025 revenue is projected to be between $72 million and $74 million, reflecting a year-over-year increase of 50% to 54% compared to Q4 2024 [2] - For the full year 2025, revenue is expected to be between $256 million and $258 million, representing growth of 51% to 52% compared to 2024 [2] Membership Growth - Total members reached approximately 886,000 as of December 31, 2025, marking a 55% increase year-over-year [2] Business Model and Strategy - The company emphasizes the relevance of its between-visit care model, which integrates human-led care teams, connected devices, and AI technology to provide personalized care [4][5] - Enhancements in GLP-1 care offerings and AI utilization are aimed at improving member outcomes and adapting to changing healthcare dynamics [4]

New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidenceSAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending a previous six-month analysis, findings underscore the program’s role in helping employers m ...

SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending a previous six-month analysis, findings underscore the program’s role in helping employers manage the complexity of today’s weight loss medication market while delivering measurable, long-term value.1 The new analysis found that members who stayed in the program ...

SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event. About Om ...

SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event. About Om ...

Core Insights - Virtual healthcare platforms are transforming patient access to care, with Hims & Hers Health, Inc. (HIMS) and GoodRx Holdings, Inc. (GDRX) leading this digital transition [2][3] Company Overview - HIMS is a subscription telehealth platform focusing on sexual health, dermatology, mental health, and weight management, allowing users to discover treatments online and consult licensed providers [2] - GDRX operates a prescription-savings marketplace that helps consumers find low-cost options and access telehealth services while expanding affordability programs [2] Stock Performance & Valuation - Over the past three months, HIMS has decreased by 9.3%, outperforming GDRX, which has dropped by 34.9%. In the past year, HIMS has increased by 19.1%, while GDRX has lost 41.6% [4] - HIMS has a forward price-to-sales (P/S) ratio of 3.2X, above its three-year median of 2.6X, while GDRX's ratio is 1.2X, below its median of 2.7X [6] Growth Strategies - HIMS is expanding into hormone health and diagnostics to enhance subscriber value and care personalization, targeting high-prevalence, recurring-care specialties [7][8] - GDRX is scaling its pharma-manufacturer services and enhancing retail integrations to improve pricing transparency and margins [11][12] Earnings Projections - The Zacks Consensus Estimate for HIMS' 2025 earnings per share (EPS) suggests a 77.8% improvement from 2024 [15] - GDRX's 2025 EPS estimate implies an 8.8% improvement from 2024 [18] Price Targets - The average price target for HIMS is $47.25, indicating a potential increase of 23.1% from the last close [20] - The average price target for GDRX is $5.14, suggesting an increase of 81.6% from the last close [21] Investment Recommendation - HIMS is viewed as a more stable investment opportunity due to improving profitability and strong cash generation, while GDRX is diversifying its revenue streams but remains exposed to retail pharmacy dynamics [25][26]

Core Insights - LifeMD's divestment of WorkSimpli will simplify its operational footprint and provide up to $22 million in cash, positioning the company as a pure play virtual healthcare entity [1] Group 1: Company Developments - LifeMD is transitioning to focus solely on virtual healthcare following the divestment of WorkSimpli [1] - The divestment is expected to enhance operational efficiency and financial liquidity for LifeMD [1] Group 2: Market Context - The equity market serves as a mechanism for wealth creation or destruction, with daily price fluctuations contributing to long-term outcomes [1] - Pacifica Yield aims to create long-term wealth by focusing on undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1]

Core Insights - Teladoc Health (TDOC) is leveraging acquisitions to enhance growth, expand distribution capabilities, broaden service offerings, and establish a global presence [1][8] Acquisition Strategy - The company focuses on acquiring scalable and rapidly growing products, capabilities, clinical specialties, technologies, and distribution channels [1] - Notable acquisitions include Healthiest You, BetterHelp, Consult-a-Doctor, AmeriDoc, InTouch Health, and Vida Health, positioning Teladoc as a leader in virtual care [2] - Recent acquisitions such as Catapult Health and Telecare have strengthened its international operations and specialist services in the Asia-Pacific region [3][4] Financial Impact - The acquisitions of Catapult Health, Uplift, and Telecare contributed 100 basis points to TDOC's revenue for the first nine months of 2025, with Integrated Care's total revenues increasing by 200 basis points [4][8] - The consensus estimate for TDOC's 2025 revenues indicates a year-over-year decline, while the estimate for 2026 suggests a year-over-year increase [10] Competitive Landscape - HCA Healthcare is also focusing on acquisitions to scale its business, leading to increased patient volumes and network expansion [5] - Elevance Health's strategic acquisitions are aimed at long-term growth, optimizing core operations [6] Stock Performance and Valuation - TDOC shares have decreased by 25.2% year to date, contrasting with the industry's growth of 4.2% [7] - The company is trading at a forward 12-month price-to-sales multiple of 0.47, slightly above the industry average of 0.46 [9]

Core Insights - Omada Health will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, with a fireside chat scheduled for 1:20 pm ET [1] Company Overview - Omada Health is a virtual healthcare provider focusing on cardiometabolic conditions such as diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues [2] - The company employs a unique approach called Compassionate Intelligence, which integrates human-led care teams, connected devices, and AI technology to deliver personalized care at scale [2] Performance and Reach - With over a decade of experience, Omada Health has published 30 peer-reviewed studies demonstrating its clinical and economic outcomes [3] - The company has served over one million members and has partnered with more than 2,000 customers, including health plans, health systems, and employers from small businesses to Fortune 500 companies [3] - Omada's evidence-based approach has led to multiple healthcare accreditations and industry recognition [3] Value Proposition - As a trusted partner in the healthcare ecosystem, Omada Health aims to improve health outcomes while managing healthcare costs effectively [4]